TrialClinical pharmacology in drug development2025

Safety and Pharmacokinetics of Long-Acting Monoclonal Antibodies Tixagevimab and Cilgavimab (AZD7442) in a China Phase 2 Study and Evaluation of Asian Race Effect.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.